Cancer · 1978 · 12 citations · 11 references
MedicineCardiologyOncologyCardio-oncologyChemotherapyEndocrine OncologyAdrenal TumorsAdverse Effects Of ChemotherapyCancer Therapy-related CardiotoxicityCytotoxic ChemotherapyEndocrine ToxicityEndocrine TumorsAcute Cardiac ToxicityAntineoplastic Drug TherapyChemotherapeutic ToxicologyLife-threatening ArrhythmiasMyocardial Ischemia MarkersPheochromocytoma DetectionPheochromocytoma DiagnosisPheochromocytoma Pathology
A 47-year-old male with histiocytic lymphoma and no previous history of heart disease developed significant fluctuations of blood pressure, electrocardiographic evidence of myocardial ischemia, and life-threatening arrhythmia after the first dose of BACOP (bleomycin, adriamycin, cyclophosphamide, Oncovin, and prednisone) chemotherapy. The presence of pheochromocytoma was suspected, and it was demonstrated by elevated urinary metanephrines, catecholamines, and vanillylmandelic acid, and finally confirmed on autopsy. The possible role of chemotherapeutic agents in stimulating excessive catecholamine release, thus causing transient cardiac injury, is suggested.
11
Cardiotoxicity of adriamycin and related anthracyclines
Luigi Lenaz, J Page · Cancer Treatment Reviews · 1976 · 373 citations
Medicine, Pharmacology, Toxicology +12
Myocardial alterations associated with pheochromocytomas.
Irwin K. Kline · PubMed · 1961 · 147 citations
R.G. Dent, Ian McColl · The Lancet · 1975 · 114 citations